The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention

2012427 citationsJournal Articlehybrid Open Access

Authors

The Diabetes Prevention Program Research Group · University of Michigan

Abstract

Over 10 years, from a payer perspective, lifestyle was cost-effective and metformin was marginally cost-saving compared with placebo. Investment in lifestyle and metformin interventions for diabetes prevention in high-risk adults provides good value for the money spent.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life Chronic Disease Management Strategies Obesity and Health Practices

Publication Details

Published in: Diabetes Care

Volume 35, Issue 4, pp. 723-730

DOI: 10.2337/dc11-1468

Field-Weighted Citation Impact: 113.05

Command Palette

The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention

Authors

Abstract

Topics & Keywords

Publication Details